The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Open accessAbstract
The anti-diabetic drug metformin targets pancreatic cancer stem cells (CSCs), but not their differentiated progenies (non-CSCs), which may be related to distinct metabolic phenotypes. Here we conclusively demonstrate that while non-CSCs were highly glycolytic, CSCs were dependent on oxidative metabolism (OXPHOS) with very limited metabolic plasticity. Thus, mitochondrial inhibition, e.g., by metformin, translated into energy crisis and apoptosis. However, resistant CSC clones eventually emerged during treatment with metformin due to their intermediate glycolytic/respiratory phenotype. Mechanistically, suppression of MYC and subsequent increase of PGC-1α were identified as key determinants for the OXPHOS dependency of CSCs, which was abolished in resistant CSC clones. Intriguingly, no resistance was observed for the mitochondrial ROS inducer menadione and resistance could also be prevented/reversed for metformin by genetic/pharmacological inhibition of MYC. Thus, the specific metabolic features of pancreatic CSCs are amendable to therapeutic intervention and could provide the basis for developing more effective therapies to combat this lethal cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High glycolytic flux is required to maintain upregulated PGD metabolism, and this in maintained in part through suppression of thioredoxin-interacting protein (TXNIP) transcription243.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [243]
Citations
Cites
Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,145
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P. D., Burant, C., Zhang, L., Adsay, V. N., Wicha, M. S., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,419
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M. O., Bruns, C. J., & Heeschen, C. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,946
Self-citationHidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Lagadinou, E. D., Sach, A., Callahan, K. P., Rossi, R. M., Neering, S. J., Minhajuddin, M., Ashton, J. M., Pei, S., Grose, V., O’Dwyer, K. M., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2012.12.013 · Cited by 1,465
LeBleu, V. S., O’Connell, J. T., Herrera, K. N. G., Wikman, H., Pantel, K., Haigis, M. C., de Carvalho, F. M., Damascena, A. S., Chinen, L. T. D., Rocha, R. M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3039 · Cited by 1,438
Cited by
Sorted by citations
Items 401–500 of 727
Xu, T., Junge, J. A., Delfarah, A., Lu, Y., Arnesano, C., Iqbal, M., Delijani, K., Hsieh, T., Hodara, E., Mehta, H. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09438-9 · Cited by 22
Divergent Roles of Mitochondria Dynamics in Pancreatic Ductal Adenocarcinoma
Carmona‐Carmona, C. A., Pozza, E. D., Ambrosini, G., Errico, A., & Dando, I. (2022) · Cancers · doi:10.3390/cancers14092155 · Cited by 23
Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis
Kim, M. S., Gernapudi, R., Cedeno, Y. C., Polster, B. M., Martinez, R., Shapiro, P., Kesari, S., Nurmemmedov, E., & Passaniti, A. (2020) · Oncotarget · doi:10.18632/oncotarget.27743 · Cited by 22
Lin, Y., Pu, S., Wang, J., Wan, Y., Wu, Z., Guo, Y., Feng, W., Ying, Y., Ma, S., Meng, X. J., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-332225 · Cited by 21
Park, B.-S., Jeon, H., Kim, Y., Kwon, H., Choi, G.-E., Chi, S.-G., Park, H.-M., Lee, H., & Kim, T. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02031-w · Cited by 22
Biagioni, A., Chillà, A., Rosso, M. D., Fibbi, G., Scavone, F., Andreucci, E., Peppicelli, S., Bianchini, F., Calorini, L., Santi, A. L., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.663225 · Cited by 21
Recent Advances in Targeted Nanotherapeutic Approaches for Breast Cancer Management
Gupta, P., Neupane, Y. R., Parvez, S., & Kohli, K. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0281 · Cited by 22
Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression
Ogunleye, A. O., Nimmakayala, R. K., Batra, S. K., & Ponnusamy, M. P. (2023) · Stem Cells · doi:10.1093/stmcls/sxad017 · Cited by 21
Lima, L. C., Domínguez, F., Domínguez‐Ramírez, L., & Cortés-Hernández, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097983 · Cited by 21
Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor
Huang, W., Gao, J., Chen, Z., Shi, H., Yuan, J., Cui, H., Yeh, C., Bränström, R., Larsson, C., Li, S., et al. (2020) · Cells · doi:10.3390/cells9061333 · Cited by 21
Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
Aftabizadeh, M., Li, Y., Zhao, Q., Zhang, C., Ambaye, N. D., Song, J., Nagao, T., Lahtz, C., Fakih, M., Ann, D. K., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.136176 · Cited by 21
Lactate Reprograms Energy and Lipid Metabolism in Glucose-Deprived Oxidative Glioma Stem Cells
Minami, N., Tanaka, K., Sasayama, T., Kohmura, E., Saya, H., & Sampetrean, O. (2021) · Metabolites · doi:10.3390/metabo11050325 · Cited by 21
Metabostemness in cancer: Linking metaboloepigenetics and mitophagy in remodeling cancer stem cells
Naik, P. P., Panigrahi, S., Parida, R., Praharaj, P. P., Bhol, C. S., Patil, S., Manjunath, N., Ghosh, D., Patra, S. K., & Bhutia, S. K. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10216-9 · Cited by 20
Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities
Sarwar, A., Zhu, M., Su, Q., Zhu, Z., Yang, T., Chen, Y., Peng, X., & Zhang, Y. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103858 · Cited by 20
Targeting Mitochondrial Metabolism to Reverse Radioresistance: An Alternative to Glucose Metabolism
Bian, C., Zheng, Z., Su, J., Wang, H., Chang, S., Xin, Y., & Jiang, X. M. (2022) · Antioxidants · doi:10.3390/antiox11112202 · Cited by 21
Improved antitumor activity against prostate cancer via synergistic targeting of Myc and GFAT-1
Zhang, Y., Li, J., Huang, Y., Chen, Y., Luo, Z., Huang, H., West, R. E., Nolin, T. D., Wang, Z., & Li, S. (2023) · Theranostics · doi:10.7150/thno.76614 · Cited by 20
Han, H., He, T., Wu, Y., He, T., & Zhou, W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1441081 · Cited by 21
Zahan, T., Das, P. K., Akter, S. F., Habib, R., Rahman, M. H., Karim, M. R., & Islam, F. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620999200730161829 · Cited by 21
Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes
Ai, J., Wörmann, S. M., Görgülü, K., Vallespinós, M., Zagorac, S., Alcalá, S., Wu, N., Kabacaoğlu, D., Berninger, A., Navarro, D., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.03.051 · Cited by 20
Zheng, K. C., Chen, S., & Hu, X. (2022) · Current Cancer Drug Targets · doi:10.2174/1568009622666220330194149 · Cited by 20
Zhang, X., Du, Y., Behrens, A., & Lan, L. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.07.002 · Cited by 19
CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition
Musicant, A. M., Parag‐Sharma, K., Gong, W., Sengupta, M., Chatterjee, A., Henry, E. C., Tsai, Y., Hayward, M. C., Sheth, S. H., Betancourt, R., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108768 · Cited by 19
Neal, M. E. H., Brenner, J. C., Prince, M. E., & Chinn, S. B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660210 · Cited by 19
Varuzhanyan, G., Chen, C., Freeland, J., Tian, H., Tran, W., Song, K., Wang, L., Cheng, D., Xu, S., DiBernardo, G., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2416882121 · Cited by 21
Zhou, X., Xiong, Z., Xiao, S., Zhou, J., Ding, Z., Ling-chao, T., Chen, X.-D., Xu, R., & Zhao, P. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s148681 · Cited by 18
RetractedThe Intricate Metabolism of Pancreatic Cancers
Camelo, F., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_5 · Cited by 19
Valcárcel-Jiménez, L., Macchia, A., Martín-Martín, N., Cortázar, A. R., Schaub-Clerigué, A., Pujana-Vaquerizo, M., Fernández‐Ruiz, S., Lacasa-Viscasillas, I., Santos-Martín, A., Loizaga‐Iriarte, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1096-6 · Cited by 20
Caria, P., Tronci, L., Dettori, T., Murgia, F., Santoru, M. L., Griffin, J. L., Vanni, R., & Atzori, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102948 · Cited by 19
Downregulation of KCTD12 contributes to melanoma stemness by modulating CD271
Shen, W. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0073 · Cited by 19
Mechanisms governing lineage plasticity and metabolic reprogramming in cancer
Perez, L. M., Venugopal, S. V., Martin, A. S., Freedland, S. J., Vizio, D. D., & Freeman, M. R. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.08.001 · Cited by 19
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies
du Toit‐Thompson, T., Leck, L. Y. W., Gillson, J., Pavlakis, N., Gill, A. J., Samra, J. S., Mittal, A., & Sahni, S. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115647 · Cited by 20
Öztürk, H., Cingoz, H., Tufan, T., Yang, J., Adair, S. J., Tummala, K. S., Kuscu, C., Kinali, M., Cömertpay, G., Nagdas, S., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.04.014 · Cited by 18
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
Parisotto, M., Vuong, N., Kalegari, P., Meharwade, T., Joumier, L., Igelmann, S., Bourdeau, V., Rowell, M., Pollak, M., Malleshaiah, M. K., et al. (2022) · Cancers · doi:10.3390/cancers14225597 · Cited by 21
Zheng, Q., Tang, J., Aicher, A., Kheir, T. B., Šabanović, B., Ananthanarayanan, P., Reina, C., Chen, M., Gu, J.-M., He, B., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02883-y · Cited by 20
Self-citationSchibler, J., Tomanek‐Chalkley, A., Reedy, J. L., Zhan, F., Spitz, D. R., Schultz, M. K., & Goel, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167323 · Cited by 17
Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells
Paiva‐Oliveira, D. I., Martins‐Neves, S. R., Abrunhosa, A., Ribeiro, C., & Gomes, C. M. F. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3467-6 · Cited by 18
Understanding the cancer stem cell phenotype: A step forward in the therapeutic management of cancer
Wong, A. L. A., Bellot, G. L., Hirpara, J. L., & Pervaiz, S. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.020 · Cited by 18
Akberdin, I. R., Kiselev, I. N., Pintus, S. S., Sharipov, R., Vertyshev, A. Y., Виноградова, О. Л., Popov, D. V., & Kolpakov, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910353 · Cited by 19
Tumor microenvironment acidosis favors pancreatic cancer stem cell properties and in vivo metastasis
Rolver, M. G., Roda, J. C., Dai, Y., Flinck, M., Ialchina, R., Hindkær, J., Dyhr, R. T., Bodilsen, A. N., Prasad, N. S., Baldan, J., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111956 · Cited by 17
Alvina, F. B., Gouw, A. M., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_12 · Cited by 17
The role of glycometabolic plasticity in cancer
Peng, Y., Yang, H., & Li, S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153595 · Cited by 17
Reyes‐Castellanos, G., Hadi, N. A., Gallardo-Arriaga, S., Masoud, R., Garcia, J., Lac, S., Kaoutari, A. E., Gicquel, T., Planque, M., Fendt, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106899 · Cited by 16
Role of Vitamin C in Targeting Cancer Stem Cells and Cellular Plasticity
Lee, Y. (2023) · Cancers · doi:10.3390/cancers15235657 · Cited by 18
Pro‑metastatic signaling of the trans fatty acid elaidic acid is associated with lipid rafts
Kishi, S., Fujiwara‐Tani, R., Luo, Y., Kawahara, I., Goto, K., Fujii, K., Ohmori, H., Nakashima, C., Sasaki, T., & Kuniyasu, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.7817 · Cited by 17
Gao, Y., Zhang, E., Fei, X., Kong, L., Liu, P., & Tan, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.691161 · Cited by 17
Quéré, M., Alberto, J., Broly, F., Hergalant, S., Christov, C., Gauchotte, G., Guéant, J., Namour, F., & Battaglia-Hsu, S.-F. (2022) · Nutrients · doi:10.3390/nu14091887 · Cited by 16
Parejo-Alonso, B., Royo-García, A., Espiau-Romera, P., Courtois, S., Curiel‐García, Á., Zagorac, S., Villaoslada, I., Olive, K. P., Heeschen, C., & Sancho, P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114162 · Cited by 17
Self-citationTumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival
Maimouni, S., Lee, M., Sung, Y.-M., Hall, M., Roy, A., Ouaari, C., Hwang, Y., Spivak, J., Glasgow, E. F., Swift, M. R., et al. (2019) · Oncotarget · doi:10.18632/oncotarget.26600 · Cited by 15
Reprogramming Oxidative Phosphorylation in Cancer: A Role for RNA-Binding Proteins
Esparza‐Moltó, P. B., & Cuezva, J. M. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7988 · Cited by 17
Organotypic Culture of Acinar Cells for the Study of Pancreatic Cancer Initiation
Carrer, A., & Paoli, C. (2020) · Cancers · doi:10.3390/cancers12092606 · Cited by 16
Esmaeili, S., Sahranavard, S., Salehi, A., & Bagheri, V. (2021) · IUBMB Life · doi:10.1002/iub.2524 · Cited by 16
Transcriptional Regulation of Stem Cell and Cancer Stem Cell Metabolism
Alptekin, A., Ye, B., & Ding, H. (2017) · Current Stem Cell Reports · doi:10.1007/s40778-017-0071-y · Cited by 16
Yang, L., Yang, J., Kong, X., Tang, Q., Song, R., Zhou, K., Quan, X., Zhang, Q., Zhang, Y., Zhang, C., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2587405 · Cited by 16
Cong, H., Gao, J. P., Wang, Q., Du, M., Li, H., Li, Q., Li, J., Liang, Y., Zhao, D., Yang, H., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.872017 · Cited by 15
Maduka, C. V., Kuhnert, M. M., Habeeb, O. M., Tundo, A., Makela, A. V., Goodman, S. B., & Contag, C. H. (2022) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2022.100069 · Cited by 15
The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention
Domínguez-Zorita, S., & Cuezva, J. M. (2023) · Cancers · doi:10.3390/cancers15153775 · Cited by 15
Garimella, S. V., Gampa, S. C., & Chaturvedi, P. (2023) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s417842 · Cited by 16
Wang, Q., Liang, N. N., Liu, C., Li, J., Bai, Y., Lei, S., Huang, Q., Sun, L., Tang, L., Zeng, C., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02418-4 · Cited by 15
Dash, S., Ueda, T., Komuro, A., Honda, M., Sugisawa, R., & Okada, H. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06531-x · Cited by 15
Konaté, M. M., Krushkal, J., Li, M., Chen, L., Kotliarov, Y., Palmisano, A., Pauly, R., Xie, Q., Williams, P. M., McShane, L. M., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05528-6 · Cited by 16
Priéto, I., Alarcon, C. R., García-Gómez, R., Berdún, R., Urgel, T., Portero‐Otín, M., Pamplona, R., Martı́nez-Ruiz, A., Ruiz-Sanz, J. I., Ruiz‐Larrea, M. B., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101396 · Cited by 15
Cash, T. P., Alcalá, S., Ferreira, M. D. R. R., Hernández-Encinas, E., García, J., Albarran, M. I., Valle, S., Muñoz, J., Martı́nez, S., Blanco‐Aparicio, C., et al. (2020) · Cancers · doi:10.3390/cancers12071790 · Cited by 15
PGC1α drives a metabolic block on prostate cancer progression
Wallace, M., & Metallo, C. M. (2016) · Nature Cell Biology · doi:10.1038/ncb3365 · Cited by 15
López‐Bonet, E., Buxó, M., Cuyàs, E., Pernas, S., Dorca, J., Álvarez, I., Torres‐Martínez, S., Pérez-García, J. M., Batista-López, N., Rodríguez‐Sánchez, C. A., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122180 · Cited by 15
Moro, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189692 · Cited by 15
Cai, W., Li, Z., Wang, W., Liu, S., Li, Y., Sun, X., Sutton, R., Deng, L., Liu, T., Xia, Q., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156538 · Cited by 15
Understanding of tumourigenesis in canine mammary tumours based on cancer stem cell research
Michishita, M. (2020) · The Veterinary Journal · doi:10.1016/j.tvjl.2020.105560 · Cited by 14
Cardio-Onco-Metabolism – Metabolic vulnerabilities in cancer and the heart
Karlstaedt, A., & Taegtmeyer, H. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.06.008 · Cited by 15
Tseng, C.-Y., Fu, Y.-H., Ou, D., Lu, J., Hou, H., & Lin, L. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00675-2 · Cited by 14
Mitonuclear Communication in Stem Cell Function
Peng, B., Wang, Y., & Zhang, H. (2024) · Cell Proliferation · doi:10.1111/cpr.13796 · Cited by 14
CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD+/NADH ratio
Hu, W., Cui, X., Liu, H., Li, Z., Chen, X., Wang, Q., Zhang, G. J., Wen, E., Lan, J., Chen, J., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03254-x · Cited by 15
Ma, T., Xie, W., Xu, Z., Gao, W., Zhou, J., Wang, Y., & Chan, F. L. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07460-z · Cited by 14
Su, H., Xue, Z., Feng, Y., Xie, Y., Deng, B., Yao, Y., Tian, X., An, Q., Yang, L., Yao, Q., et al. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114789 · Cited by 14
Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition
Arasanz, H., Hernández, C., Bocanegra, A., Chocarro, L., Zuazo, M., Gato, M., Ausín, K., Santamaría, E., Fernández‐Irigoyen, J., Fernández, G., et al. (2020) · Cancers · doi:10.3390/cancers12082181 · Cited by 14
Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer
Hussein, S., Khanna, P., Yunus, N., & Gatza, M. L. (2021) · Cancers · doi:10.3390/cancers13194808 · Cited by 15
The Intricate Metabolism of Pancreatic Cancers
Camelo, F. S., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_5 · Cited by 15
Wnorowski, A., Dudzik, D., Bernier, M., Wójcik, J., Keijzers, G., Díaz‐Ruiz, A., Mazur, K., Zhang, Y., Han, H., Scheibye‐Knudsen, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07600-x · Cited by 14
A Shifty Target: Tumor-Initiating Cells and Their Metabolism
Bezuidenhout, N., & Shoshan, M. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215370 · Cited by 16
Yu, Q., Jiang, K., Ma, S., Zheng, Q., Tondi, S., Reina, C., Šabanović, B., Wen, C., Shen, B., Aicher, A., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.004 · Cited by 13
Self-citationXu, Y., Xue, D., Kyani, A., Bankhead, A., Roy, J., Ljungman, M. E., & Neamati, N. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00069 · Cited by 15
Ibello, E., Saracino, F., Cave, D. D., Buonaiuto, S., Amoroso, F., Andolfi, G., Corona, M., Guardiola, O., Colonna, V., Sáinz, B., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03072-1 · Cited by 13
Sasaki, R., Luo, Y., Kishi, S., Ogata, R., Nishiguchi, Y., Sasaki, T., Ohmori, H., Fujiwara‐Tani, R., & Kuniyasu, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031192 · Cited by 14
Knockdown of HMGB1 Suppresses Hypoxia-Induced Mitochondrial Biogenesis in Pancreatic Cancer Cells
Yang, L., Ye, F., Zeng, L., Li, Y., & Chai, W. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s234530 · Cited by 13
Repas, J., Zügner, E., Gole, B., Bizjak, M., Potočnik, U., Magnes, C., & Pavlin, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-98642-0 · Cited by 14
Pandit, S. K., Sandrini, G., Merulla, J., Nobili, V., Wang, X., Zangari, A., Rinaldi, A., Shinde, D. A., Carbone, G. M., & Catapano, C. V. (2021) · Cancers · doi:10.3390/cancers13236029 · Cited by 13
Ghildiyal, R., & Sen, E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.12.008 · Cited by 13
Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
Renz, B. W., D’Haese, J. G., Werner, J., Westphalen, C. B., & Ilmer, M. (2017) · Medical Sciences · doi:10.3390/medsci5020014 · Cited by 14
Mitochondrial metabolism in cancer stem cells (CSCs): molecular and diagnostic implications
Psvv, C., Sunil, S., Thuyyath, N., Kokkanti, R. R., & Lavudi, K. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1741800 · Cited by 13
Pleiotropic Regulation of PGC-1α in Tumor Initiation and Progression
Zhang, Y., Zhao, H., & Li, Y. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0506 · Cited by 14
Aria, H., Azizi, M., Nazem, S., Mansoori, B., Darbeheshti, F., Niazmand, A., Daraei, A., & Mansoori, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35208 · Cited by 12
Rolver, M. G., Severin, M., & Pedersen, S. F. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00429.2024 · Cited by 12
Anti-Cancer and Pro-Immune Effects of Lauric Acid on Colorectal Cancer Cells
Mori, S., Fujiwara‐Tani, R., Ogata, R., Ohmori, H., Fujii, K., Luo, Y., Sasaki, T., Nishiguchi, Y., BHAWAL, U. K., Kishi, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051953 · Cited by 12
Jü, R., Fei, K., Li, S.-A., Chen, C., Zhu, L., Li, J., Zhang, D., Guo, L., & Ye, C. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.249326 · Cited by 12
Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer
Wu, Z., Lee, Y. F., Yeo, X. H., Loo, S. Y., & Tam, W. L. (2021) · Cancers · doi:10.3390/cancers13061316 · Cited by 14
Targeting autophagy in pancreatic cancer: The cancer stem cell perspective
Troumpoukis, D., Papadimitropoulou, A., Charalampous, C., Kogionou, P., Palamaris, K., Sarantis, P., & Serafimidis, I. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1049436 · Cited by 12
Inacio, K. K., Pessôa, A. D. S., Tokuhara, C. K., Pagnan, A. L., Sanches-Silva, A. T., Fakhoury, V. S., de Oliveira, G. S. N., de Oliveira, F. A., Ximenes, V. F., & de Oliveira, R. C. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109840 · Cited by 12
IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer
Li, X., Huang, G., Xu, Z.-L., Zhao, C., Dong, X.-Y., Cui, B., & Lin, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04800-5 · Cited by 12
More challenges ahead—metabolic heterogeneity of pancreatic cancer stem cells
Heeschen, C., & Sancho, P. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1105353 · Cited by 12
Self-citationDujardin, P., Baginska, A. K., Urban, S., & Grüner, B. M. (2021) · Cancers · doi:10.3390/cancers13164187 · Cited by 12
Developing Bi-Gold Compound BGC2a to Target Mitochondria for the Elimination of Cancer Cells
Cui, Q., Ding, W., Liu, P., Luo, B., Yang, J., Lu, W., Hu, Y., Huang, P., & Wen, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012169 · Cited by 12
Metadata
- Authors
- Sancho, P., Burgos-Ramos, E., Tavera, A., Bou Kheir, T., Jagust, P., Schoenhals, M., Barneda, D., Sellers, K., Campos-Olivas, R., Graña, O., Viera, C. R., Yuneva, M., Sainz, B., & Heeschen, C.
- Affiliations
- Queen Mary University of London (GB)
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Sancho, Patricia
- Heeschen, Christopher
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 22
- Issue
- 4
- Pages
- 590-605
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W1892036645
- Cited by
- 722
- References
- 44
- Citations by year
- 2026: 36 · 2025: 51 · 2024: 60 · 2023: 72 · 2022: 79 · 2021: 88 · 2020: 94 · 2019: 79 · 2018: 65 · 2017: 51 · 2016: 41 · 2015: 5
- FWCI
- 17.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- RUIdeRA - Institutional University Repository (University of Castilla-La Mancha) (submittedVersion, other-oa)
- Funders
- Francis Crick Institute (10223)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic cancer stem cells, c-Myc, PGC-1α, metformin, oxidative phosphorylation, glycolysis, metabolic plasticity, drug resistance, mitochondrial reactive oxygen species, menadione, apoptosis, energy crisis, cancer metabolism
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, AC133 Antigen, Animals, Antineoplastic Agents, Glycoproteins, Humans, Metformin, Mice, Nude, Mitochondria, Oxidative Phosphorylation, Pancreatic Neoplasms, Peptides, Phenotype, Transcription Factors, Tumor Cells, Cultured, Neoplastic Stem Cells, Antigens, CD, Gene Library, Proto-Oncogene Proteins c-myc, Reactive Oxygen Species, Drug Resistance, Neoplasm, Vitamin K 3, RNA Interference, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
